<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1007601.ref065">
 <label>65</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Sunay</surname>
   <given-names>MM</given-names>
  </name>, 
  <name>
   <surname>Foote</surname>
   <given-names>JB</given-names>
  </name>, 
  <name>
   <surname>Leatherman</surname>
   <given-names>JM</given-names>
  </name>, 
  <name>
   <surname>Edwards</surname>
   <given-names>JP</given-names>
  </name>, 
  <name>
   <surname>Armstrong</surname>
   <given-names>TD</given-names>
  </name>, 
  <name>
   <surname>Nirschl</surname>
   <given-names>CJ</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo</article-title>. 
  <source>Int Immunopharmacol</source>. 
  <year>2017</year>;
  <volume>46</volume>:
  <fpage>112</fpage>â€“
  <lpage>23</lpage>. Epub 2017/03/11. 
  <pub-id pub-id-type="doi">10.1016/j.intimp.2017.02.028</pub-id>
  <?supplied-pmid 28282575?>
  <pub-id pub-id-type="pmid">28282575</pub-id>
 </mixed-citation>
</ref>
